NAFITHROMYCIN (MIKNAF) 350 mg, 6 tablets

Miqnaf (Nafithromycin): A Next-Generation Macrolide Targeting Respiratory Tract Infections

Within the antibacterial arsenal, new molecules periodically emerge, ready to address challenges where traditional agents falter. Miqnaf is the commercial name for an innovative antibiotic, Nafithromycin. It belongs to the macrolide class and comes in 350 mg film-coated tablets. The standard pack of 6 is no accident; it represents a single, complete cycle of therapy. Here’s a detailed breakdown of what distinguishes this agent and how to use it responsibly.

🧪 Beneath the Coating: Formula and Mechanism

Each white, round tablet carries the engraving "N" on one face. Inside, it contains 385 mg of nafithromycin calcium trihydrate, chemically equivalent to 350 mg of pure nafithromycin.

The medication is categorized as a macrolide antibiotic — a family renowned for its ability to inhibit protein synthesis within bacterial cells. This disruption halts the growth and multiplication of pathogens, empowering the body’s immune system to neutralize the infection source more rapidly.

📋 When a Doctor Prescribes Miqnaf

The agent’s primary therapeutic territory lies in the lower respiratory tract. Official indications include:

• Community-Acquired Pneumonia: Lung inflammation arising outside a hospital setting.
• Acute Bacterial Bronchitis: Confirmed bronchial inflammation caused by susceptible bacterial flora.

Crucially, the decision to prescribe rests exclusively with a physician, grounded in clinical evaluation and microbiological data. Self-diagnosis is strictly inadmissible here.

⚠️ Red Flags: Absolute Contraindications

A set of conditions mandates the absolute avoidance of Nafithromycin:

• Hypersensitivity: Known intolerance to nafithromycin, any other macrolide antibiotics, or the tablet’s excipients.
• Liver Impairment: Severe, decompensated hepatic dysfunction.
• Cardiac Safety: Concurrent administration with substances capable of triggering serious rhythm disturbances (QT interval prolongation). These include terfenadine, astemizole, cisapride, and pimozide.
• Pediatric Population: Individuals under 18 years of age, due to insufficient data on efficacy and safety.

🔍 Zones Requiring Heightened Caution

Some clinical scenarios demand tighter physician monitoring:

• Mild to moderate hepatic impairment.
• Pre-existing conditions predisposing the patient to cardiac arrhythmias.
• Pregnancy and breastfeeding: the drug is utilized only when the anticipated benefit to the mother clearly outweighs any potential fetal or neonatal risk.

💊 Dosing Regimen: Simplicity and Adherence

The administration schedule is designed for high patient compliance:

• Frequency: One tablet, once daily.
• Course Duration: Exactly 6 days. One pharmacy pack delivers one complete treatment cycle.
• Mode of Administration: The tablet is swallowed whole, aided by a full glass of water. Chewing should be avoided.
• Food Relation: Food intake does not compromise the drug’s absorption, yet physicians advise taking it at the same time each day. This practice helps sustain a uniform blood concentration.

Discipline matters profoundly: never discontinue the course halfway simply because symptoms improve. The infection must be eradicated entirely; otherwise, relapse and bacterial drug resistance become a tangible threat.

📊 Adverse Effect Spectrum: What to Anticipate

All antibiotics carry a profile of undesired reactions. For Nafithromycin, the most commonly encountered are:

• Gastrointestinal: abdominal discomfort or pain, diarrheal syndrome, nausea, vomiting.
• Nervous System: episodic headaches.

Other, less frequent occurrences include:

• Allergic immune responses (rash, urticaria, itching).
• Transient elevation of liver enzymes (ALT, AST) in blood work.
• Mucosal candidiasis (oral or genital thrush).

Should any concerning reaction appear, stop taking the tablets and contact your treating physician immediately.

🔗 Interactions with Other Medications

Always disclose any drugs you take — be they prescription, over-the-counter, or herbal — to your doctor.

• Strict Contraindication for Co-administration: Terfenadine, astemizole, cisapride, pimozide (as noted above).
• Enhanced Caution Required: Agents metabolized in the liver via the CYP3A4 enzyme pathway — their plasma levels may increase significantly.
• Antacids: Heartburn remedies reduce nafithromycin absorption. Maintain a minimum two-hour gap between their intake and that of the antibiotic.

🛡️ Special Precautions and Counsel

• If no clinical improvement is evident after several days of treatment, or if the condition deteriorates, seek urgent medical advice.
• As with other antibiotics, treatment-associated diarrhea — including the severe form known as pseudomembranous colitis — may develop during the course. This symptom warrants an immediate medical response.
• The drug exerts no influence on reaction speed or the capacity to operate vehicles or heavy machinery; driving is permissible during treatment.

📦 Storage and Legal Status

Store the tablets away from light, in a dry environment at a temperature not exceeding 25°C, retained within their original packaging. The shelf life is 2 years.
Legal Category: Dispensed strictly via medical prescription. Active substance manufactured by WOCKHARDT (India). The marketing authorization holder in Russia is Pharmstandard-Leksredstva, JSC.

📦Find out about the delivery to your country on WhatsApp

Important notice

The photograph is provided for product identification. Packaging design may vary by batch or market. This page provides general product information and does not replace the package leaflet, diagnosis, prescription or advice from a doctor or pharmacist.